{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041577","form_type":"8-K","ticker":"MTNB","cik":"0001582554","company_name":"Matinas BioPharma Holdings, Inc.","filed_at":"2026-09-04T21:00:30+00:00","discovered_at":"2026-09-04T21:02:00.552358+00:00","generated_at":"2026-09-04T21:02:11.266260+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Matinas BioPharma receives NYSE American non-compliance notice for equity below $2M","bullets":["Received notice Aug 31, 2026: stockholders' equity $1.8M as of June 30, 2026, below $2.0M minimum under Section 1003(a)(i).","Also non-compliant with Sections 1003(a)(ii) and (iii) (equity below $4M and $6M) as previously disclosed.","Plan accepted by NYSE American; plan period through Oct 2, 2027 to regain compliance; delisting proceedings if not.","No immediate impact on listing; shares continue trading on NYSE American under MTNB with .BC indicator."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041577","json":"https://secwatch.observer/filing/0001493152-26-041577.json","markdown":"https://secwatch.observer/filing/0001493152-26-041577.md","text":"https://secwatch.observer/filing/0001493152-26-041577.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582554/000149315226041577/0001493152-26-041577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582554/000149315226041577/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-04T21:02:11.266260+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}